NTRBW
Nutriband Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.51
Beta
1.93
52W High
$4.50
52W Low
$0.80
50-Day MA
$1.39
200-Day MA
$1.72
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Nutriband Inc. Warrant
Nutriband Inc. Warrant (NTRBW) represents a strategic investment opportunity linked to Nutriband Inc., a pioneering biotech company that specializes in advanced transdermal drug delivery systems. Focusing primarily on enhancing patient care within pain management and addiction treatment, Nutriband is committed to addressing critical unmet medical needs through its innovative therapeutic pipeline. With its cutting-edge technologies and a robust approach to drug administration, the company is well-positioned to capitalize on growth opportunities in the evolving pharmaceutical landscape, making it a compelling prospect for institutional investors seeking exposure to the biotech sector.
Fundamentals
| Revenue (TTM) | $2.28M |
| Gross Profit (TTM) | 763,310 |
| EBITDA | $-9.03M |
| Operating Margin | -1121.00% |
| Return on Equity | -136.10% |
| Return on Assets | -55.20% |
| Revenue/Share (TTM) | $0.20 |
| Book Value | $0.62 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -46.40% |
| Shares Outstanding | 0 |
| Float | $4.91M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/9/2026